Cerebrospinal Fluid Biomarkers of Central Nervous System Inflammation Predict Cortical Decline in Bipolar Disorder and Ventricular Enlargement in Healthy Controls
Neuropsychobiology · 2024
DOI: 10.1159/000542888 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropsychobiology, 2024. Verfasst von Tobias Bellaagh Johansson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothe…. Hauptthemen laut MEDLINE: Bipolar Disorder, Chitinase-3-Like Protein 1, Interleukin-8, Interleukin-6. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Bipolar disorder has been associated with significant structural brain changes, potentially driven by central nervous system (CNS) inflammation. This study aimed to investigate the relationship between inflammation biomarkers in cerebrospinal fluid (CSF) and longitudinal structural brain changes.
Methods
We included 29 individuals with bipolar disorder and 34 healthy controls, analyzing three selected inflammation-related biomarkers – interleukin-6 (IL-6), interleukin-8 (IL-8), and chitinase-3-like protein 1 (YKL-40) – in both blood serum and CSF. Structural brain changes were assessed through magnetic resonance imaging at two timepoints, focusing on cortical thickness of the middle temporal cortex and inferior frontal gyrus, as well as ventricular volume.
Results
In healthy controls, baseline CSF levels of YKL-40 predicted ventricular enlargement in both hemispheres. Among individuals with bipolar disorder, higher baseline levels of IL-8 were associated with a decline in cortical thickness in the right and left middle temporal cortex, as well as the right inferior frontal gyrus. No significant associations were observed with serum biomarkers.
Conclusions
These findings suggest that CSF IL-8 may contribute to cortical decline in bipolar disorder. The lack of association between serum biomarkers and brain changes highlights the specificity of CNS inflammation in these processes. Additionally, the observed link between CSF YKL-40 and ventricular enlargement in healthy controls may indicate a role of CNS inflammation processes in normal brain aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
- Centre for Cognitive and Computational Neuropsychiatry, Karolinska Institutet, Stockholm, Sweden.
- Department Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
- Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet and Stockholm Health Care Services, Stockholm, Sweden.
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Zitieren
APA
Bellaagh Johansson, T., Klahn, A. L., Göteson, A., Abé, C., Sellgren, C. M., & Landén, M. (2024). Cerebrospinal Fluid Biomarkers of Central Nervous System Inflammation Predict Cortical Decline in Bipolar Disorder and Ventricular Enlargement in Healthy Controls. Neuropsychobiology. https://doi.org/10.1159/000542888
Vancouver
Bellaagh Johansson T, Klahn AL, Göteson A, Abé C, Sellgren CM, Landén M. Cerebrospinal Fluid Biomarkers of Central Nervous System Inflammation Predict Cortical Decline in Bipolar Disorder and Ventricular Enlargement in Healthy Controls. Neuropsychobiology. 2024. doi:10.1159/000542888
BibTeX
@article{BellaaghJohansson2024,
author = {Bellaagh Johansson, Tobias and Klahn, Anna Luisa and Göteson, Andreas and Abé, Christoph and Sellgren, Carl M and Landén, Mikael},
title = {Cerebrospinal Fluid Biomarkers of Central Nervous System Inflammation Predict Cortical Decline in Bipolar Disorder and Ventricular Enlargement in Healthy Controls},
journal = {Neuropsychobiology},
year = {2024},
doi = {10.1159/000542888}
}
EUVIMED